Compare AMKR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMKR | RVTY |
|---|---|---|
| Founded | 1968 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.8B |
| IPO Year | 1998 | N/A |
| Metric | AMKR | RVTY |
|---|---|---|
| Price | $46.82 | $95.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | $52.88 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 4.9M | 1.6M |
| Earning Date | 02-09-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.70% | 0.29% |
| EPS Growth | ★ 4.89 | N/A |
| EPS | 1.50 | ★ 2.07 |
| Revenue | ★ $6,707,981,000.00 | $2,856,051,000.00 |
| Revenue This Year | $10.39 | $6.06 |
| Revenue Next Year | $9.87 | $5.15 |
| P/E Ratio | ★ $31.65 | $46.68 |
| Revenue Growth | ★ 6.18 | 3.67 |
| 52 Week Low | $14.03 | $81.36 |
| 52 Week High | $57.09 | $120.39 |
| Indicator | AMKR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 35.98 |
| Support Level | $42.14 | $93.70 |
| Resistance Level | $57.09 | $106.55 |
| Average True Range (ATR) | 3.77 | 4.25 |
| MACD | -0.38 | -1.69 |
| Stochastic Oscillator | 30.70 | 7.12 |
Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.